| 1 |
receptor for advanced glycation end products
(2809 times)
|
Biochemistry
(298 times)
|
HMGB1 (533 times)
AGEs (225 times)
sRAGE (204 times)
|
1995 The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
|
| 2 |
receptor for AGEs
(657 times)
|
Biochemistry
(96 times)
|
AGEs (459 times)
AGE (135 times)
ROS (60 times)
|
1993 Expression of receptors for advanced glycosylation end products on renal cell carcinoma cells in vitro.
|
| 3 |
AGE receptor
(64 times)
|
Biochemistry
(10 times)
|
AGEs (35 times)
AGE (23 times)
ROS (6 times)
|
1997 Advanced glycation end products, oxidant stress and vascular lesions.
|
| 4 |
Rating Scale for Aggressive Behaviour in the Elderly
(7 times)
|
Geriatrics
(6 times)
|
MMSE (2 times)
AD (1 time)
BARS (1 time)
|
1997 Aggressive behaviour in the Chinese elderly--validation of the Chinese version of the rating scale for aggressive behaviour in the elderly (RAGE) in hospital and nursing home settings.
|
| 5 |
AGEs-their receptor
(4 times)
|
Medicine
(4 times)
|
AGEs (4 times)
ROS (1 time)
VEGF (1 time)
|
2005 Possible participation of advanced glycation end products in the pathogenesis of colorectal cancer in diabetic patients.
|
| 6 |
rapid amplification of genomic ends
(3 times)
|
Molecular Biology
(2 times)
|
PCR (2 times)
gDNA (1 time)
|
1997 Rapid amplification of gene ends (RAGE) from gene libraries by anchored PCR.
|
| 7 |
recombinase-assisted genome engineering
(3 times)
|
Science
(2 times)
|
BAC (1 time)
GT (1 time)
Mpn (1 time)
|
2013 Implementation of stable and complex biological systems through recombinase-assisted genome engineering.
|
| 8 |
RNAi-Assisted Genome Evolution
(3 times)
|
Biotechnology
(2 times)
|
RNAi (1 time)
|
2014 Genome-wide RNAi screen reveals the E3 SUMO-protein ligase gene SIZ1 as a novel determinant of furfural tolerance in Saccharomyces cerevisiae.
|
| 9 |
RAGEDeltacyto
(2 times)
|
Cell Biology
(1 time)
|
SCs (1 time)
|
2010 Human muscle satellite cells show age-related differential expression of S100B protein and RAGE.
|
| 10 |
random activation of gene expression
(2 times)
|
Biotechnology
(1 time)
|
cDNA (1 time)
EST (1 time)
HTS (1 time)
|
2001 Creation of genome-wide protein expression libraries using random activation of gene expression.
|
| 11 |
rapid acquisition gradient-echo
(2 times)
|
Diagnostic Imaging
(1 time)
|
IPH (1 time)
MP (1 time)
MR (1 time)
|
1997 Gadolinium-enhanced breath-hold three-dimensional time-of-flight MR angiography of the abdominal and pelvic vessels: the value of ultrafast MP-RAGE sequences.
|
| 12 |
rapid gradient-echo
(2 times)
|
Diagnostic Imaging
(2 times)
|
MP (1 time)
SIR (1 time)
TOF (1 time)
|
1993 Three-dimensional MR imaging of the coronary arteries: preliminary clinical experience.
|
| 13 |
Recent understanding of this process has confirmed that AGE-their receptor
(2 times)
|
Medicine
(2 times)
|
AGEs (2 times)
TAGE (2 times)
AD (1 time)
|
2005 Potential therapeutic implication of nifedipine, a dihydropyridine-based calcium antagonist, in advanced glycation end product (AGE)-related disorders.
|
| 14 |
redox balance, expression of the AGE receptor
(2 times)
|
Biochemistry
(2 times)
|
AGEs (2 times)
GLP-1 (1 time)
|
2010 Glucagon-like peptide-1 counteracts the detrimental effects of Advanced Glycation End-Products in the pancreatic beta cell line HIT-T 15.
|
| 15 |
reducing receptor for AGEs
(2 times)
|
Metabolism
(2 times)
|
AGEs (2 times)
ROS (2 times)
ADMA (1 time)
|
2012 Pravastatin inhibits advanced glycation end products (AGEs)-induced proximal tubular cell apoptosis and injury by reducing receptor for AGEs (RAGE) level.
|
| 16 |
region of advanced glycosylation end-product specific receptor
(2 times)
|
Heart Failure
(1 time)
|
AD (1 time)
CI (1 time)
HF (1 time)
|
2020 Association of rs2070600 in advanced glycosylation end-product specific receptor with prognosis of heart failure.
|
| 17 |
renal tumor antigen
(2 times)
|
Neoplasms
(2 times)
|
HCC (1 time)
MALDI-PSD (1 time)
MMP-9 (1 time)
|
1998 Direct identification of major histocompatibility complex class I-bound tumor-associated peptide antigens of a renal carcinoma cell line by a novel mass spectrometric method.
|
| 18 |
research advanced glycation end-product receptors
(2 times)
|
Otorhinolaryngologic Diseases
(1 time)
|
3'-UTR (1 time)
ARE (1 time)
SGC (1 time)
|
2004 AU-rich elements in the mRNA 3'-untranslated region of the rat receptor for advanced glycation end products and their relevance to mRNA stability.
|
| 19 |
restriction analysis of gene expression
(2 times)
|
Pathology
(1 time)
|
RT-PCR (1 time)
|
2003 Tyrosine-kinase expression profiles in human gastric cancer cell lines and their modulations with retinoic acids.
|
| 20 |
role of AGEs and their receptor
(2 times)
|
Cell Biology
(2 times)
|
AGEs (2 times)
DM (1 time)
IL (1 time)
|
2010 Advanced glycation end products, oxidative stress and diabetic nephropathy.
|
| 21 |
AGE-specific receptor
(1 time)
|
Rheumatology
(1 time)
|
AGE (1 time)
IgG (1 time)
OA (1 time)
|
2004 Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis.
|
| 22 |
anti-AGE receptor
(1 time)
|
Allergy and Immunology
(1 time)
|
AGE-HSA (1 time)
AGEs (1 time)
ECs (1 time)
|
2007 Advanced glycation end products induce actin rearrangement and subsequent hyperpermeability of endothelial cells.
|
| 23 |
Currently, advanced glycation end product
(1 time)
|
Neoplasms
(1 time)
|
CI (1 time)
sRAGE (1 time)
WMD (1 time)
|
2014 Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis.
|
| 24 |
down-regulate the mRNA level of the AGE receptor
(1 time)
|
Biochemistry
(1 time)
|
AGEs (1 time)
CAT (1 time)
EGCG (1 time)
|
2007 Protective effect of (-)-epigallocatechin gallate against advanced glycation endproducts-induced injury in neuronal cells.
|
| 25 |
radical scavenging; AGE cross-link breaking; AGE receptor
(1 time)
|
Biology
(1 time)
|
AGE (1 time)
AGEs (1 time)
|
2006 Advanced glycation endproducts (AGEs): Pharmacological inhibition in diabetes.
|
| 26 |
RAGE Ab
(1 time)
|
Allergy and Immunology
(1 time)
|
at-HMGB1 (1 time)
DRG (1 time)
ds-HMGB1 (1 time)
|
2014 Identification of a functional interaction of HMGB1 with Receptor for Advanced Glycation End-products in a model of neuropathic pain.
|
| 27 |
RAGE gene knockout
(1 time)
|
Cardiology
(1 time)
|
ALI (1 time)
ARDS (1 time)
IL (1 time)
|
2017 Role of Receptor for Advanced Glycation End Products in Regulating Lung Fluid Balance in Lipopolysaccharide-induced Acute Lung Injury and Infection-Related Acute Respiratory Distress Syndrome.
|
| 28 |
Rage KO
(1 time)
|
Endocrinology
(1 time)
|
AT2 (1 time)
KO (1 time)
|
2010 Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor.
|
| 29 |
RAGE-apt
(1 time)
|
Natural Science Disciplines
(1 time)
|
AGE (1 time)
ALDO (1 time)
CML (1 time)
|
2018 RAGE-aptamer attenuates deoxycorticosterone acetate/salt-induced renal injury in mice.
|
| 30 |
RAGE-aptamers
(1 time)
|
Endocrinology
(1 time)
|
AGEs (1 time)
|
2017 RAGE-Aptamer Blocks the Development and Progression of Experimental Diabetic Nephropathy.
|
| 31 |
RAGE-v
(1 time)
|
Biochemistry
(1 time)
|
---
|
2016 Biophysical characterization of Ca2+-binding of S100A5 and Ca2+-induced interaction with RAGE.
|
| 32 |
raised against receptor for AGEs
(1 time)
|
Endocrinology
(1 time)
|
ADMA (1 time)
AGEs (1 time)
DDAH (1 time)
|
2013 Involvement of advanced glycation end product-induced asymmetric dimethylarginine generation in endothelial dysfunction.
|
| 33 |
Raman-Activated Gravity-Driven Encapsulation
(1 time)
|
|
RACS (1 time)
RAGE-Seq (1 time)
|
2021 One-Cell Metabolic Phenotyping and Sequencing of Soil Microbiome by Raman-Activated Gravity-Driven Encapsulation (RAGE).
|
| 34 |
RANKL and receptor for AGE
(1 time)
|
Endocrinology
(1 time)
|
OPG (1 time)
RANK (1 time)
RANKL (1 time)
|
2014 RANKL-OPG and RAGE modulation in vascular calcification and diabetes: novel targets for therapy.
|
| 35 |
Rapid analysis of gene expression
(1 time)
|
Biochemistry
(1 time)
|
---
|
1999 Rapid analysis of gene expression (RAGE) facilitates universal expression profiling.
|
| 36 |
recently, AGE-their receptor
(1 time)
|
Medicine
(1 time)
|
AGE (1 time)
AGEs (1 time)
|
2005 Therapeutic potentials of unicellular green alga Chlorella in advanced glycation end product (AGE)-related disorders.
|
| 37 |
Recently, the activation of the advanced glycation endproducts receptor
(1 time)
|
Vascular Diseases
(1 time)
|
NFAT (1 time)
siRNA (1 time)
STAT (1 time)
|
2011 RAGE-dependent activation of the oncoprotein Pim1 plays a critical role in systemic vascular remodeling processes.
|
| 38 |
receptor expression for AGEs
(1 time)
|
Cardiology
(1 time)
|
AGE-HSA (1 time)
AGEs (1 time)
EMSA (1 time)
|
2008 Advanced glycation end products depress function of endothelial progenitor cells via p38 and ERK 1/2 mitogen-activated protein kinase pathways.
|
| 39 |
receptor for advanced AGEs
(1 time)
|
|
ACS (1 time)
AGEs (1 time)
cTnI (1 time)
|
2012 Inverse Association between Cardiac Troponin-I and Soluble Receptor for Advanced Glycation End Products in Patients with Non-ST-Segment Elevation Myocardial Infarction.
|
| 40 |
receptor for advanced glycation end products advanced glycation end products
(1 time)
|
Neoplasms
(1 time)
|
CRC (1 time)
HMGB1 (1 time)
NF-kappaB (1 time)
|
2018 Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
|
| 41 |
receptor for glycer-AGEs
(1 time)
|
Chemistry
(1 time)
|
GLAP (1 time)
ROS (1 time)
RT-PCR (1 time)
|
2020 Glyceraldehyde-Derived Pyridinium Evokes Renal Tubular Cell Damage via RAGE Interaction.
|
| 42 |
receptor gene for advanced glycation
(1 time)
|
Gynecology
(1 time)
|
---
|
2010 Implication of the RAGE-EN-RAGE axis in endometriosis.
|
| 43 |
receptor ligation
(1 time)
|
Nutritional Sciences
(1 time)
|
AGEs (1 time)
COX-2 (1 time)
MAPK (1 time)
|
2006 Effects of flavonoids on the expression of the pro-inflammatory response in human monocytes induced by ligation of the receptor for AGEs.
|
| 44 |
receptor of AGE expression
(1 time)
|
Nephrology
(1 time)
|
AGEs (1 time)
HPMC (1 time)
PD (1 time)
|
2002 AGEs bind to mesothelial cells via RAGE and stimulate VCAM-1 expression.
|
| 45 |
Receptor pro konene produkty pokroile glykace
(1 time)
|
Internal Medicine
(1 time)
|
AGEs (1 time)
|
2014 [Receptor pro konene produkty pokroile glykace (RAGE) - kliovy hra diabeticke angiopatie?].
|
| 46 |
receptor protein for AGE
(1 time)
|
Medicine
(1 time)
|
AD (1 time)
AGEs (1 time)
sRAGE (1 time)
|
2012 Induction of neuronal death by microglial AGE-albumin: implications for Alzheimer's disease.
|
| 47 |
receptor was investigated for AGE
(1 time)
|
Ophthalmology
(1 time)
|
AGEs (1 time)
CEC (1 time)
|
2003 Expression and function of receptors for advanced glycation end products in bovine corneal endothelial cells.
|
| 48 |
receptors including those of the final glucosiding product
(1 time)
|
Physiology
(1 time)
|
---
|
2006 [Participation of the DNA-binding cytokine amphoterine in triggering the processes of tissue reparation].
|
| 49 |
receptors of end-glycosylated products
(1 time)
|
Cell Membrane
(1 time)
|
ACE2 (1 time)
RAS (1 time)
|
2021 The Balance between Two Branches of RAS Can Protect from Severe COVID-19 Course.
|
| 50 |
receptors placed on neighboring cells
(1 time)
|
Biochemistry
(1 time)
|
AGE (1 time)
|
2011 Transmission of prions within the gut and towards the central nervous system.
|
| 51 |
receptors, including advanced glycation end product-specific receptor
(1 time)
|
Nephrology
(1 time)
|
AGEs (1 time)
|
2015 Uremic Toxicity of Advanced Glycation End Products in CKD.
|
| 52 |
recognized by AGE receptors
(1 time)
|
Chemistry, Clinical
(1 time)
|
AGEs (1 time)
NF-kB (1 time)
|
2006 Glycation endproducts in osteoporosis--is there a pathophysiologic importance?
|
| 53 |
recombination-dependent activatable gene expression
(1 time)
|
Biochemistry
(1 time)
|
AR (1 time)
beta-AR (1 time)
EGFP (1 time)
|
2006 Inducible model for beta-six-mediated site-specific recombination in mammalian cells.
|
| 54 |
reduce the expression of AGEs-induced AGEs receptor
(1 time)
|
Molecular Biology
(1 time)
|
AGEs (1 time)
APOE (1 time)
ATV (1 time)
|
2020 Effect of atorvastatin on AGEs-induced injury of cerebral cortex via inhibiting NADPH oxidase -NF-kappaB pathway in ApoE-/- mice.
|
| 55 |
reductase pathway and the increased AGE interactions with its receptor
(1 time)
|
Science
(1 time)
|
AGEs (1 time)
|
2005 Aldose reductase and AGE-RAGE pathways: key players in myocardial ischemic injury.
|
| 56 |
regulated by the AGES-receptor
(1 time)
|
Cell Biology
(1 time)
|
AGEs (1 time)
VSMC (1 time)
|
2016 Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.
|
| 57 |
regulated by the membrane receptors for Abeta1-42 peptides
(1 time)
|
Pharmacology
(1 time)
|
---
|
2012 Anti-Abeta-MAb and dually decorated nanoliposomes: effect of Abeta1-42 peptides on interaction with hCMEC/D3 cells.
|
| 58 |
related to AGE-receptor for AGE
(1 time)
|
Nephrology
(1 time)
|
AGE (1 time)
GDP (1 time)
PDF (1 time)
|
2005 Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
|
| 59 |
relatively little AGE-receptor
(1 time)
|
Nephrology
(1 time)
|
AGE-HSA (1 time)
|
1999 The use of optical sensors to understand cellular interactions with renal cells.
|
| 60 |
Removal of alleles by genome editing
(1 time)
|
Biology
(1 time)
|
---
|
2019 Removal of alleles by genome editing (RAGE) against deleterious load.
|
| 61 |
removal of deleterious alleles by genome editing
(1 time)
|
Biology
(1 time)
|
---
|
2019 Removal of alleles by genome editing (RAGE) against deleterious load.
|
| 62 |
renal AGEs-receptor
(1 time)
|
Biochemistry
(1 time)
|
AGEs (1 time)
CC (1 time)
CML (1 time)
|
2021 Ezetimibe attenuates experimental diabetes and renal pathologies via targeting the advanced glycation, oxidative stress and AGE-RAGE signalling in rats.
|
| 63 |
renal hypertrophy as well as overexpression of AGE receptors
(1 time)
|
Endocrinology
(1 time)
|
AGE (1 time)
LZ (1 time)
MS (1 time)
|
2008 Orally administered microencapsulated lysozyme downregulates serum AGE and reduces the severity of early-stage diabetic nephropathy.
|
| 64 |
renaturing agarose gel electrophoresis
(1 time)
|
Toxicology
(1 time)
|
AE (1 time)
DDC (1 time)
DPC (1 time)
|
1998 Differential sensitivity of chromium-mediated DNA interstrand crosslinks and DNA-protein crosslinks to disruption by alkali and EDTA.
|
| 65 |
Research Diagnostics, Flanders, NJ
(1 time)
|
Brain
(1 time)
|
AD (1 time)
|
2008 Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.
|
| 66 |
response is attributed to apically oriented AGE receptors
(1 time)
|
Ophthalmology
(1 time)
|
AGE (1 time)
DME (1 time)
RPE (1 time)
|
2015 Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure.
|
| 67 |
responses, AGE receptors
(1 time)
|
Neurology
(1 time)
|
LBs (1 time)
MDAL (1 time)
PD (1 time)
|
2010 Involvement of the cerebral cortex in Parkinson disease linked with G2019S LRRK2 mutation without cognitive impairment.
|
| 68 |
Rhythmic Analysis of Gene Expression
(1 time)
|
Medical Informatics
(1 time)
|
---
|
2003 Phase-independent rhythmic analysis of genome-wide expression patterns.
|
| 69 |
robust increase in both myocardial AGE receptor
(1 time)
|
Cell Biology
(1 time)
|
AGEs (1 time)
CD (1 time)
|
2018 Reduced Susceptibility to Sugar-Induced Metabolic Derangements and Impairments of Myocardial Redox Signaling in Mice Chronically Fed with D-Tagatose when Compared to Fructose.
|
| 70 |
role of advanced glycation end products(AGEs) and their receptor
(1 time)
|
Ophthalmology
(1 time)
|
AGEs (1 time)
|
2005 [Molecular mechanism of diabetic retinopathy: role of advanced glycation end products(AGEs) and their receptor (RAGE) in the pathogenesis of diabetic retinopathy].
|
| 71 |
role of AGEs and of their specific receptors
(1 time)
|
Endocrinology
(1 time)
|
AGEs (1 time)
|
2001 Advanced glycation end products, their receptors and diabetic angiopathy.
|
| 72 |
roles of high-mobility group box-1, advanced glycation end-products receptors
(1 time)
|
Pharmacology
(1 time)
|
---
|
2009 Inflammation in ischaemic brain injury: current advances and future perspectives.
|
| 73 |
rotavirus acute gastroenteritis
(1 time)
|
Allergy and Immunology
(1 time)
|
RV (1 time)
|
2013 A reverse evidence of rotavirus vaccines impact.
|
| 74 |
ruling out effects of cellular advanced glycation end product receptor
(1 time)
|
Dermatology
(1 time)
|
---
|
2002 Photosensitized growth inhibition of cultured human skin cells: mechanism and suppression of oxidative stress from solar irradiation of glycated proteins.
|
| 75 |
superfamily--receptor for advanced glycation endproducts
(1 time)
|
Therapeutics
(1 time)
|
FH1 (1 time)
|
2015 The multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic disease.
|
| 76 |
up-regulation of receptor for AGEs
(1 time)
|
Pharmacology
(1 time)
|
AGEs (1 time)
GS (1 time)
IL-6 (1 time)
|
2014 Polyphenol isolated from Corni Fructus, 7-O-galloyl-D-sedoheptulose, modulates advanced glycation endproduct-related pathway in type 2 diabetic db/db mice.
|
| 77 |
up-regulation of the advanced glycation end product receptors
(1 time)
|
Cell Biology
(1 time)
|
HMGB1 (1 time)
|
2011 Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein.
|
A Search Service for Abbreviation / Long Form